These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9572539)

  • 21. Nonsteroidal eye drops for ocular allergy.
    Schwab IR
    West J Med; 1994 Dec; 161(6):594-5. PubMed ID: 7856163
    [No Abstract]   [Full Text] [Related]  

  • 22. A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study Group.
    Pannuti F; Robustelli della Cuna G; Ventaffrida V; Strocchi E; Camaggi CM
    Tumori; 1999; 85(2):96-100. PubMed ID: 10363074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.
    Brint SF; Cheetham JK; DeGryse R; Abel ML; Thompson VM; Rosenthal A
    J Cataract Refract Surg; 1999 Jan; 25(1):41-9. PubMed ID: 9888075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer.
    Minotti V; Betti M; Ciccarese G; Fumi G; Tonato M; Del Favero A
    Pharmacotherapy; 1998; 18(3):504-8. PubMed ID: 9620101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group.
    Yee RW
    Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
    Shulman DG; Lothringer LL; Rubin JM; Briggs RB; Howes J; Novack GD; Hart K
    Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketorolac: a new antiinflammatory for seasonal allergic conjunctivitis.
    Holdcroft C
    Nurse Pract; 1994 May; 19(5):30. PubMed ID: 8065646
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis.
    Discepola M; Deschenes J; Abelson M
    Acta Ophthalmol Scand Suppl; 1999; (228):43-6. PubMed ID: 10337432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.
    Mortemousque B; Bourcier T; Khairallah M; Messaoud R; Brignole-Baudouin F; Renault D; Rebika H; Brémond-Gignac D;
    J Fr Ophtalmol; 2014 Jan; 37(1):1-8. PubMed ID: 24388379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
    Celik T; Turkoglu EB
    Curr Eye Res; 2014 Jan; 39(1):42-6. PubMed ID: 24074291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of topical ketorolac and diclofenac on normal corneal sensation.
    Sun R; Gimbel HV
    J Refract Surg; 1997; 13(2):158-61. PubMed ID: 9109072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
    Abelson MB; Berdy GJ; Mundorf T; Amdahl LD; Graves AL;
    J Ocul Pharmacol Ther; 2002 Oct; 18(5):475-88. PubMed ID: 12419098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison between ketorolac and diclofenac in laparoscopic sterilization.
    Chui PT; Gin T
    Eur J Anaesthesiol; 1995 Nov; 12(6):597-601. PubMed ID: 8665883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corneal sensitivity and burning sensation. Comparing topical ketorolac and diclofenac.
    Seitz B; Sorken K; LaBree LD; Garbus JJ; McDonnell PJ
    Arch Ophthalmol; 1996 Aug; 114(8):921-4. PubMed ID: 8694724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Flach AJ; Dolan BJ
    Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis.
    D'Angelo G; Lambiase A; Cortes M; Sgrulletta R; Pasqualetti R; Lamagna A; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):192-5. PubMed ID: 12644942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of bepotastine besilate ophthalmic solution 1.5% for seasonal allergic conjunctivitis: a randomized, placebo-controlled, natural exposure, clinical trial.
    Carr WW; Nayak AS; Ratner PH; Gow JA; McNamara TR; Williams JI;
    Allergy Asthma Proc; 2013; 34(3):247-54. PubMed ID: 23484763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.